|
FIGNL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.75010000053244E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.413500E-04 |
| Normal-vs-Stage2 |
2.471500E-02 |
| Normal-vs-Stage3 |
1.963110E-03 |
| Normal-vs-Stage4 |
7.612400E-02 |
| Stage1-vs-Stage2 |
9.800600E-01 |
| Stage1-vs-Stage3 |
1.433830E-01 |
| Stage1-vs-Stage4 |
3.435800E-01 |
| Stage2-vs-Stage3 |
3.331000E-01 |
| Stage2-vs-Stage4 |
4.542000E-01 |
| Stage3-vs-Stage4 |
9.885400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.77860000008623E-07 |
| Normal-vs-AfricanAmerican |
5.898200E-03 |
| Normal-vs-Asian |
1.341170E-01 |
| Caucasian-vs-AfricanAmerican |
1.459840E-01 |
| Caucasian-vs-Asian |
5.284200E-01 |
| AfricanAmerican-vs-Asian |
8.880600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.90180000001228E-06 |
| Normal-vs-Female |
1.39850000002717E-06 |
| Male-vs-Female |
6.738300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.024300E-03 |
| Normal-vs-Extreme_Weight |
4.583900E-03 |
| Normal-vs-Obese |
4.22420000000256E-05 |
| Normal-vs-Extreme_Obese |
1.860990E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.611200E-01 |
| Normal_Weight-vs-Obese |
5.414400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.631600E-01 |
| Extreme_Weight-vs-Obese |
6.506400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.125800E-01 |
| Obese-vs-Extreme_Obese |
2.313800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.130180E-02 |
| Normal-vs-Age(41-60Yrs) |
8.47869999764939E-08 |
| Normal-vs-Age(61-80Yrs) |
2.759500E-04 |
| Normal-vs-Age(81-100Yrs) |
2.826200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.224200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.696000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.644430E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.438200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.600580E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.975000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.3357999995598E-07 |
| Normal-VS-Type2 PRCC |
2.871900E-02 |
| Normal-VS-KIRP CIMP |
3.254000E-02 |
| Normal-VS-Unclassified PRCC |
4.385100E-04 |
| Type1 PRCC-VS-Type2 PRCC |
5.481900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.420000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.968790E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.188000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.607910E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.556800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.096280E-02 |
| Normal-vs-N1 |
5.367400E-04 |
| Normal-vs-N2 |
3.791200E-01 |
| N0-vs-N1 |
9.495800E-03 |
| N0-vs-N2 |
4.144000E-01 |
| N1-vs-N2 |
4.868400E-01 |
|
|
